US Patent Issued to California Institute of Technology, 1200 Pharma, The Regents of the University of California on March 24 for "PRMT5 inhibitors and uses thereof" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,859, issued on March 24, was assigned to California Institute of Technology (Pasadena, Calif.), 1200 Pharma LLC (Culver City, Calif.) and The Regents of the University of California (Oakland, Calif.).

"PRMT5 inhibitors and uses thereof" was invented by Brendan M. O'Boyle (Monrovia, Calif.), Corey M. Reeves (San Mateo, Calif.), Justin A. Hilf (Los Angeles), Brian M. Stoltz (San Marino, Calif.), Michael D. Bartberger (Sherman Oaks, Calif.), Steven J. Wittenberger (Sherman Oaks, Calif.), Oliver C. Loson (Culver City, Calif.), Martina S. McDermott (Los Angeles), Neil A. O'Brien (Los Angeles) and Dennis Slamon (Los Angeles).

According to the abstract* released by the U.S. Patent & Tr...